- Tissue injury repair via novel targets and inhibitors
- Granzymes–an exciting new extracellular target
- Pathopysiological roles for Granzyme B in Discoid Lupus Erythematosus
- DLE development pathway
…and much more!
Get your copy here!
To find out more about viDA Therapeutics Inc. and Granzyme B , attend World Orphan Drug Congress USA 2016 April 20-22 in Washington, DC.